Mouwasat Medical Services Company Financials

Market Capitalization SR15.31 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	22.78
Forward PE	17.44
Price to Sales TTM	SR5.24
Price to Book MRQ	SR4.07
Enterprise to Revenue	5.25
Enterprise to EBITDA	15.71

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	22.98%
Operating Margin	27.90%
Return on Assets TTM	8.40%
Return on Equity TTM	18.54%

Income Statement

Revenue TTM	SR2,920,935,424
Revenue per Share TTM	SR14.61
Quarterly Revenue Growth	5.80%
Gross Profit TTM	SR1,267,884,800
EBITDA	SR1,047,617,632
Net Income to Common TTM	SR671,225,792
Diluted EPS TTM	SR3.36
Quarterly Earnings Growth YoY	14.80%

Balance Sheet

Total Cash MRQ	SR699,883,392
Total Cash per Share MRQ	SR3.50
Total Debt MRQ	SR
Total Debt to Equity MRQ	20.45
Current Ratio MRQ	2.21
Book Value per Share MRQ	SR18.83

Cash Flow

Operating Cash Flow TTM	SR1,278,255,488
Levered Free Cash Flow TTM	SR632,316,288

4002 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	200,000,000
Float Shares	94,940,000
Avg 10 Volume	319,330
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	54.58%
% Held by Institutions	6.97%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	SR65.60
Fifty Two Week High	SR125.00
Fifty Two Week Change	-58.95%
Day 50 MA	SR73.84
Day 200 MA	SR83.76

Dividends and Splits

Forward Annual Dividend Rate	SR8.00
Forward Annual Dividend Yield	10.49%
Trailing Annual Dividend Rate	SR2.00
Trailing Annual Dividend Yield	2.62%
Payout Ratio	52.08%
Dividend Date
Ex Dividend Date	2025-05-06
Last Split Factor
Last Split Date	2023-08-08